Prognostic and predictive value of a novel 100-point scale in patients with T1–2N0M0 breast cancer

QR Code

Prognostic and predictive value of a novel 100-point scale in patients with T1–2N0M0 breast cancer

Aim. To increase the efficacy of systemic breast cancer therapy and reduce inappropriate prescriptions using individual immunohistochemical tumor characteristics, as well as to develop prognostic scales to ensure a tailored approach to adjuvant systemic treatment in breast cancer patients. Materia...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. M. Paltuev, A. G. Kudaybergenova, V. F. Semiglazov, A. S. Artemyeva, T. Yu. Semiglazova, A. V. Komyakhov, O. A. Volynshchikova, V. V. Klimenko, M. M. Urezkova
Format:	Article
Language:	Russian
Published:	ABV-press 2023-06-01
Series:	Опухоли женской репродуктивной системы
Subjects:	breast cancer biomarkers prognostic scale breast cancer prognosis
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/1077
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic value of FOXA1 in patients with Т1–2N0M0 breast cancer
by: R. M. Paltuev, et al.
Published: (2023-08-01)

Prognostic value of CD4<sup>+</sup> in patients with Т1–2N0M0 breast cancer
by: R. M. Paltuev, et al.
Published: (2023-08-01)

The role of biomarkers in the early diagnostics of breast cancer
by: A. Kh. Ismagilov, et al.
Published: (2021-03-01)

Current standards for the treatment of metastatic breast cancer (According to the proceedings of the International Conference on Breast Cancer, Moscow, January 22–24, 2014)
by: V. P. Letyagin, et al.
Published: (2014-07-01)

SPINAL METASTASES IN BREAST CANCER PATIENTS. PROGNOSTIC FACTORS
by: М. D. Aliev, et al.
Published: (2016-02-01)

Discordance of Estrogen Receptor Status Between Primary and Metastatic Breast Cancer: Possible Reasons and Prognostic Value
by: T. A. Bogush, et al.
Published: (2020-05-01)

Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01)

AUTOMATED ANALYSIS OF CELL DENSITY IN BREAST CANCER AS AN ADDITIONAL METHOD OF INCREASING OBJECTIVITY AND ACCURACY OF BREAST CANCER PROGNOSIS
by: R. M. Paltuev, et al.
Published: (2017-09-01)

THE RATIO OF TISSUE COMPONENTS AND PROGNOSTIC INDICES OF HISTOLOGICAL VARIANTS OF INFILTRATING TYPE OF BREAST CANCER
by: V. V. Kometova, et al.
Published: (2017-01-01)

Reticulon 4 in Breast Cancer: A Comprehensive Analysis of its Biomarker Potential for Prognosis, Immunology, and Drug Sensitivity
by: Tuğcan Korak, et al.
Published: (2025-07-01)

The influence of functional skewness on prognosis of cancer of mammary gland
by: L. E. Erendeeva, et al.
Published: (2002-03-01)

Prognostic factors in T3–Т4N0M0 breast cancer
by: I. V. Vysotskaya, et al.
Published: (2014-08-01)

PREDICTORS OF A LOCAL RECURRENCE AFTER ORGAN-PRESERVING TREATMENT FOR EARLY BREAST CANCER: STATE-OF-THE-ART
by: N. R. Molodikova, et al.
Published: (2014-09-01)

A Prognostic Nutritional Index-Based Nomogram to Predict Breast Cancer Metastasis: A Retrospective Cohort Validation
by: Chen Z, et al.
Published: (2025-06-01)

Multifactorial Analysis of Prognostic and Predictive Biomarkers in Triple Negative Breast Cancer Patients
by: V. N. Pavlov, et al.
Published: (2025-07-01)

NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER
by: V. F. Semiglazov, et al.
Published: (2018-07-01)

Current standards for primary breast cancer treatment (According to the proceedings of the International Conference on Breast Cancer, Moscow, January 22–24, 2014)
by: V. P. Letyagin, et al.
Published: (2014-07-01)

Predictive and prognostic features of early and locally advanced <i>PIK3CA</i>-mutated luminal HER2-negative breast cancer
by: A. I. Stukan, et al.
Published: (2024-01-01)

Biological rationale for patient-specific treatment of breast cancer. Analysis of new data for breast cancer
by: R. M. Paltuev
Published: (2020-03-01)

Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?
by: Ana-Alicia Beltran-Bless, et al.
Published: (2025-10-01)

Prognostic value of a lncRNA signature in early-stage invasive breast cancer patients
by: Rong Guo, et al.
Published: (2025-06-01)

The Identification of Novel Prognostic and Predictive Biomarkers in Breast Cancer via the Elucidation of Tumor Ecotypes Using Ecotyper
by: Feng Du, et al.
Published: (2025-08-01)

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
by: E. A. Bus’ko, et al.
Published: (2017-02-01)

Population factors predicting survival in breast cancer: analysis according to the data of the Arkhangelsk Regional Cancer Registry in 2000–2020
by: A. V. Agaeva, et al.
Published: (2023-06-01)

Predicting the site of distant metastases in breast cancer
by: E. S. Grigoryeva, et al.
Published: (2023-02-01)

ROLE OF PROGNOSTIC FACTORS IN THE DEVELOPMENT OF CENTRIC BREAST CANCER RECURRENCE
by: E. A. Sotskova, et al.
Published: (2014-09-01)

PREGNANCY IN WOMEN WITH A HISTORY OF BREAST CANCER
by: A. A. Parokonnaya, et al.
Published: (2014-09-01)

The basic mechanisms the influence of metabolic syndrome on the risk and prognosis of breast cancer (review)
by: I. B. Schepotin, et al.
Published: (2014-07-01)

Sentinel lymph node biopsy in patients with breast cancer ycT4N0M0 after neoadjuvant drug therapy
by: M. B. Kurbanova, et al.
Published: (2024-05-01)

The role of digital mammography, scintimammography with <sup>99m </sup>Tc-methoxyisobutylisonitrile (MIBI) and ultrasound in the diagnosis of multicentric breast cancer
by: A. V. Chernaya, et al.
Published: (2020-03-01)

Cytokeratin expression in breast cancer: from mechanisms, progression, diagnosis, and prognosis to therapeutic implications
by: Ensiyeh Bahadoran, et al.
Published: (2025-12-01)

Clinical characteristics and treatment advances in isolated axillary lymph node recurrence after breast cancer surgery
by: DU Xinyue, WU Siyu, LIU Guangyu
Published: (2025-06-01)

RADIATION THERAPY OF BREAST CANCER WITH ACCOUNT PROGNOSTIC FACTORS
by: K. A. Simonov, et al.
Published: (2016-02-01)

The clinical value of p53 and the parameters of DNA-flow cytofluorometry in combination with clinical and morphological predictors in breast cancer
by: L. K. Tsoi, et al.
Published: (2014-08-01)

CONTROVERSIAL ISSUES IN THE TREATMENT OF PATIENTS WITH T3N0–2M0 LARYNGEAL FOLD CANCER
by: A. Sh. Taneeva, et al.
Published: (2015-04-01)

Combination of pregnancy and breast cancer
by: A. L. Chernyshova, et al.
Published: (2023-10-01)

The association between intrinsic breast cancer subtypes, mammography screening and prognosis: a large population-based real world cohort study
by: Santeri Palmi, et al.
Published: (2025-08-01)

Assessment of <i>ERBB2</i> and HER2 expression in metastatic breast cancer using the nCounter® system and a 100-gene scale
by: R. M. Paltuev, et al.
Published: (2023-10-01)

Predictive multigenic scale. Analysis of own results in metastatic breast cancer
by: R. M. Paltuev, et al.
Published: (2023-06-01)

LONG-TERM PROGNOSIS IN PATIENTS WITH A LOCAL BREAST CANCER RELAPSE AFTER ORGAN-SAVING TREATMENT
by: V. A. Uimanov, et al.
Published: (2014-09-01)